In 2022, the Clinical Proteomic Tumour Analysis Consortium (CPTAC) investigated cancer cells, known for being massively altered, and explained how DNA ...

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked.